{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T08:43:02Z","timestamp":1742200982164,"version":"3.38.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-025-04031-2","type":"journal-article","created":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T08:02:30Z","timestamp":1742198550000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The role of C4d expression in the diagnosis of bullous pemphigoid: a clinical and histopathological study"],"prefix":"10.1007","volume":"317","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4059-9946","authenticated-orcid":false,"given":"\u015eeyhmus","family":"Kaya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9418-8862","authenticated-orcid":false,"given":"Ramazan O\u011fuz","family":"Y\u00fcceer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6189-8016","authenticated-orcid":false,"given":"Mustafa","family":"Tosun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2016-8623","authenticated-orcid":false,"given":"Reikhan","family":"Mustafaeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,17]]},"reference":[{"issue":"10","key":"4031_CR1","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.3390\/biom10101432","volume":"10","author":"F Moro","year":"2020","unstructured":"Moro F, Fania L, Sinagra JLM, Salemme A, Di Zenzo G (2020) Bullous pemphigoid: trigger and predisposing factors. Biomolecules 10(10):1432","journal-title":"Biomolecules"},{"issue":"3","key":"4031_CR2","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1111\/bjd.20743","volume":"186","author":"MS Persson","year":"2022","unstructured":"Persson MS, Begum N, Grainge MJ, Harman KE, Grindlay D, Gran S (2022) The global incidence of bullous pemphigoid: a systematic review and meta-analysis. Br J Dermatol 186(3):414\u2013425","journal-title":"Br J Dermatol"},{"key":"4031_CR3","doi-asserted-by":"crossref","unstructured":"Yang W, Cai X, Zhang S, Han X, Ji L (2020) Dipeptidyl peptidase-4 inhibitor treatment and the risk of bullous pemphigoid and skin-related adverse events: A systematic review and meta-analysis of randomized controlled trials. Diabetes\/Metabolism Research and Reviews, p e3391","DOI":"10.1002\/dmrr.3391"},{"issue":"12","key":"4031_CR4","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1111\/jdv.13660","volume":"30","author":"Y Lai","year":"2016","unstructured":"Lai Y, Yew Y, Lambert W (2016) Bullous pemphigoid and its association with neurological diseases: a systematic review and meta-analysis. J Eur Acad Dermatol Venereol 30(12):2007\u20132015","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"4031_CR5","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/bjd.19022","volume":"184","author":"MSM Persson","year":"2021","unstructured":"Persson MSM, Harman KE, Vinogradova Y, Langan SM, Hippisley-Cox J, Thomas KS, Gran S (2021) Incidence, prevalence and mortality of bullous pemphigoid in England 1998\u20132017: a population\u2010based cohort study. Br J Dermatol 184(1):68\u201377","journal-title":"Br J Dermatol"},{"issue":"2","key":"4031_CR6","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1080\/09546634.2020.1782325","volume":"33","author":"PM Garrido","year":"2022","unstructured":"Garrido PM, Queir\u00f3S CS, Travassos AR, Borges-Costa J, Filipe P (2022) Emerging treatments for bullous pemphigoid. J Dermatological Treat 33(2):649\u2013661","journal-title":"J Dermatological Treat"},{"issue":"6","key":"4031_CR7","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1111\/j.1600-0560.2008.01129.x","volume":"36","author":"W Chandler","year":"2009","unstructured":"Chandler W, Zone J, Florell S (2009) C4d immunohistochemical stain is a sensitive method to confirm immunoreactant deposition in formalin-fixed paraffin-embedded tissue in bullous pemphigoid. J Cutan Pathol 36(6):655\u2013659","journal-title":"J Cutan Pathol"},{"issue":"5","key":"4031_CR8","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.jaad.2008.06.022","volume":"59","author":"CM Magro","year":"2008","unstructured":"Magro CM, Dyrsen ME (2008) The use of C3d and C4d immunohistochemistry on formalin-fixed tissue as a diagnostic adjunct in the assessment of inflammatory skin disease. J Am Acad Dermatol 59(5):822\u2013833","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"4031_CR9","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/jid.2010.357","volume":"131","author":"SM Langan","year":"2011","unstructured":"Langan SM, Groves RW, West J (2011) The relationship between neurological disease and bullous pemphigoid: a population-based case\u2013control study. J Invest Dermatology 131(3):631\u2013636","journal-title":"J Invest Dermatology"},{"issue":"1","key":"4031_CR10","doi-asserted-by":"publisher","first-page":"13","DOI":"10.5021\/ad.2018.30.1.13","volume":"30","author":"HW Jeon","year":"2018","unstructured":"Jeon HW, Yun SJ, Lee SC, Won YH, Lee JB (2018) Mortality and comorbidity profiles of patients with bullous pemphigoid in Korea. Ann Dermatol 30(1):13\u201319","journal-title":"Ann Dermatol"},{"key":"4031_CR11","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0190-9622(80)80247-7","volume":"3","author":"JP Callen","year":"1980","unstructured":"Callen JP (1980) Internal disorders associated with bullous disease of the skin. J Am Acad Dermatol 3:107\u2013119","journal-title":"J Am Acad Dermatol"},{"key":"4031_CR12","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/0738-081X(87)90051-4","volume":"5","author":"MV Dahl","year":"1987","unstructured":"Dahl MV (1987) Bullous pemphigoid: associated diseases. Clin Dermatol 5:64\u201370","journal-title":"Clin Dermatol"},{"key":"4031_CR13","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/ajd.12764","volume":"59","author":"RJ Lucariello","year":"2018","unstructured":"Lucariello RJ, Villablanca E, Mascar\u00f3 S, Reichel J, M (2018) Association between bullous pemphigoid and malignancy: A meta-analysis. Australas J Dermatol 59:253\u2013260","journal-title":"Australas J Dermatol"},{"issue":"2","key":"4031_CR14","doi-asserted-by":"publisher","first-page":"2280991","DOI":"10.1080\/07853890.2023.2280991","volume":"55","author":"R Huang","year":"2023","unstructured":"Huang R, Hu L, Jiang F (2023) Study of cytokine-induced immunity in bullous pemphigoid: recent developments. Ann Med 55(2):2280991","journal-title":"Ann Med"},{"key":"4031_CR15","doi-asserted-by":"publisher","first-page":"1144429","DOI":"10.3389\/fimmu.2023.1144429","volume":"14","author":"T Yan","year":"2023","unstructured":"Yan T, Zhang Z (2023) Adaptive and innate immune pathogenesis of bullous pemphigoid: A review. Front Immunol 14:1144429","journal-title":"Front Immunol"},{"key":"4031_CR16","doi-asserted-by":"publisher","first-page":"912876","DOI":"10.3389\/fimmu.2022.912876","volume":"13","author":"C Cole","year":"2022","unstructured":"Cole C, Vinay K, Borradori L, Amber KT (2022) Insights into the pathogenesis of bullous pemphigoid: the role of complement-independent mechanisms. Front Immunol 13:912876","journal-title":"Front Immunol"},{"issue":"2","key":"4031_CR17","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/1346-8138.16654","volume":"50","author":"H Ujiie","year":"2023","unstructured":"Ujiie H (2023) What\u2019s new in the pathogeneses and triggering factors of bullous pemphigoid. J Dermatol 50(2):140\u2013149","journal-title":"J Dermatol"},{"key":"4031_CR18","doi-asserted-by":"publisher","first-page":"152367","DOI":"10.1016\/j.anndiagpath.2024.152367","volume":"73","author":"S Karaba\u011f","year":"2024","unstructured":"Karaba\u011f S, Zorlu \u00d6 (2024) Diagnosis of autoimmune bullous dermatoses: comparative analysis of immunohistochemical staining using C4d, C3d, IgG, and IgG4 in lesional tissues and perilesional frozen skin samples. Annals Diagn Pathol 73:152367","journal-title":"Annals Diagn Pathol"},{"key":"4031_CR19","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.jdcr.2020.04.008","volume":"6","author":"R Boardman","year":"2020","unstructured":"Boardman R, Horvath B, Boling MC, Pas HH, Diercks GFH (2020) Immunoglobulin M bullous pemphigoid; an enigma. JAAD Case Rep 6:518\u2013520","journal-title":"JAAD Case Rep"},{"issue":"10","key":"4031_CR20","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1097\/DAD.0000000000001873","volume":"43","author":"J Damman","year":"2021","unstructured":"Damman J, Edwards G, van Doorn MB, Horvath B, Diercks GF (2021) Diagnostic utility of C4d by direct Immunofluorescence in bullous pemphigoid. Am J Dermatopathol 43(10):727\u2013729","journal-title":"Am J Dermatopathol"},{"issue":"3","key":"4031_CR21","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1097\/DAD.0000000000000333","volume":"38","author":"AP Villani","year":"2016","unstructured":"Villani AP, Chouvet B, Kanitakis J (2016) Application of C4d immunohistochemistry on routinely processed tissue sections for the diagnosis of autoimmune bullous dermatoses. Am J Dermatopathol 38(3):186\u2013188","journal-title":"Am J Dermatopathol"},{"issue":"5","key":"4031_CR22","first-page":"767","volume":"27","author":"EES Mohammed Soliman","year":"2021","unstructured":"Mohammed Soliman EES, ElKashishy KA, Metwally MI, Hassan AM (2021) The diagnostic roles of C4D expression in some auto\u0131mmune bullous dermatoses In Zagaz\u0131g Un\u0131vers\u0131ty hosp\u0131tals; an immunohistochemical study. Zagazig Univ Med J 27(5):767\u2013775","journal-title":"Zagazig Univ Med J"},{"key":"4031_CR23","doi-asserted-by":"crossref","unstructured":"Sneha Muppala R, Basavaraj V (2024) Role of C4d immunohistochemical marker in the diagnosis of bullous pemphigoid: A cross-sectional study. Indian J Dermatology Venereol Leprology, 90(5)","DOI":"10.25259\/IJDVL_124_2023"},{"issue":"1","key":"4031_CR24","doi-asserted-by":"publisher","first-page":"10519","DOI":"10.1038\/s41598-022-14950-z","volume":"12","author":"H Oh","year":"2022","unstructured":"Oh H, Kim CH, Lee YJ (2022) Bullous pemphigoid diagnosis: the role of routine formalin-fixed paraffin-embedded skin tissue immunochemistry. Sci Rep 12(1):10519","journal-title":"Sci Rep"},{"issue":"19","key":"4031_CR25","doi-asserted-by":"publisher","first-page":"10526","DOI":"10.3390\/ijms251910526","volume":"25","author":"D Kowalska","year":"2024","unstructured":"Kowalska D, Bie\u0144kowski M, Jurkowska P, Kawecka A, Kury\u0142o J, Ku\u017aniewska A, Okr\u00f3j M (2024) Accurate visualization of C4d complement fragment in immunohistochemistry by C-Terminal linear Neoepitope-Specific antibodies. Int J Mol Sci 25(19):10526","journal-title":"Int J Mol Sci"},{"issue":"2","key":"4031_CR26","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1111\/bjd.12936","volume":"171","author":"T Schmidt","year":"2014","unstructured":"Schmidt T, Sitaru C, Amber K, Hertl M (2014) BP180- and BP230-Specific IgG autoantibodies in pruritic disorders of the elderly: A preclinical stage of bullous pemphigoid?? Br J Dermatol 171(2):212\u2013219. https:\/\/doi.org\/10.1111\/bjd.12936","journal-title":"Br J Dermatol"},{"issue":"12","key":"4031_CR27","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1111\/ijd.15589","volume":"60","author":"C Sun","year":"2021","unstructured":"Sun C, Feng S (2021) Recent developments in the pathogenesis of pruritus in bullous pemphigoid. Int J Dermatol 60(12):1441\u20131448","journal-title":"Int J Dermatol"},{"issue":"5","key":"4031_CR28","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1016\/j.jaci.2017.12.1002","volume":"141","author":"J Meng","year":"2018","unstructured":"Meng J, Moriyama M, Feld M, Buddenkotte J, Buhl T, Szollosi A et al (2018) New mechanism underlying IL-31-Induced atopic dermatitis. J Allergy Clin Immunol 141(5):1677\u20131689e8","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"4031_CR29","doi-asserted-by":"publisher","first-page":"847","DOI":"10.3390\/ph17070847","volume":"17","author":"J Kowalska","year":"2024","unstructured":"Kowalska J, Wrze\u015bniok D (2024) Skin-Related adverse reactions induced by oral antidiabetic Drugs\u2014A review of literature and case reports. Pharmaceuticals 17(7):847","journal-title":"Pharmaceuticals"},{"issue":"3","key":"4031_CR30","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/exd.14228","volume":"30","author":"PM Patel","year":"2021","unstructured":"Patel PM, Jones VA, Kridin K, Amber KT (2021) The role of dipeptidyl peptidase-4 in cutaneous disease. Exp Dermatol 30(3):304\u2013318","journal-title":"Exp Dermatol"},{"issue":"9","key":"4031_CR31","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.4239\/wjd.v12.i9.1426","volume":"12","author":"A Roy","year":"2021","unstructured":"Roy A, Sahoo J, Narayanan N, Merugu C, Kamalanathan S, Naik D (2021) Dipeptidyl peptidase-4 inhibitor-induced autoimmune diseases: current evidence. World J Diabetes 12(9):1426","journal-title":"World J Diabetes"},{"key":"4031_CR32","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s12026-018-9005-8","volume":"66","author":"K Kridin","year":"2018","unstructured":"Kridin K, Amber K, Khamaisi M, Comaneshter D, Batat E, Cohen AD (2018) Is there an association between dipeptidyl peptidase-4 inhibitors and autoimmune disease? Immunol Res 66:425\u2013430","journal-title":"Immunol Res"},{"key":"4031_CR33","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00592-020-01533-5","volume":"57","author":"YC Chen","year":"2020","unstructured":"Chen YC, Chen TH, Sun CC, Chen JY, Chang SS, Yeung L, Tsai YW (2020) Dipeptidyl peptidase-4 inhibitors and the risks of autoimmune diseases in type 2 diabetes mellitus patients in Taiwan: a nationwide population-based cohort study. Acta Diabetol 57:1181\u20131192","journal-title":"Acta Diabetol"},{"issue":"2","key":"4031_CR34","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1177\/10600280211022722","volume":"56","author":"L Sun","year":"2022","unstructured":"Sun L, Wang C, Wu C, Zhou Y, Wang C (2022) Analysis of the clinical characteristics of dipeptidyl Peptidase-4 Inhibitor\u2013Induced bullous pemphigoid. Ann Pharmacother 56(2):205\u2013212","journal-title":"Ann Pharmacother"},{"key":"4031_CR35","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1001\/jamadermatol.2018.4556","volume":"155","author":"SG Lee","year":"2019","unstructured":"Lee SG, Lee HJ, Yoon MS, Kim DH (2019) Association of dipeptidyl peptidase 4 inhibitor use with risk of bullous pemphigoid in patients with diabetes. JAMA Dermatol 155:172\u2013177","journal-title":"JAMA Dermatol"},{"key":"4031_CR36","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1016\/j.jid.2016.06.622","volume":"136","author":"K Izumi","year":"2016","unstructured":"Izumi K, Nishie W, Mai Y, Wada M, Natsuga K, Ujiie H, Iwata H, Yamagami J, Shimizu H (2016) Autoantibody profile differentiates between inflammatory and noninflammatory bullous pemphigoid. J Invest Dermatol 136:2201\u20132210","journal-title":"J Invest Dermatol"},{"key":"4031_CR37","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1111\/1346-8138.14245","volume":"45","author":"C Chijiwa","year":"2018","unstructured":"Chijiwa C, Takeoka S, Kamata M, Tateishi M, Fukaya S, Hayashi K, Fukuyasu A, Tanaka T, Ishikawa T, Ohnishi T, Watanabe S, Tada Y (2018) Decrease in eosinophils infiltrating into the skin of patients with dipeptidyl peptidase-4 inhibitor-related bullous pemphigoid. J Dermatol 45:596\u2013599","journal-title":"J Dermatol"},{"issue":"4","key":"4031_CR38","first-page":"455","volume":"156","author":"F Bellinato","year":"2020","unstructured":"Bellinato F, Maurelli M, Schena D, Gisondi P, Girolomoni G (2020) Clinical and immunological profile of patients with dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid. Italian J Dermatology Venereol 156(4):455\u2013459","journal-title":"Italian J Dermatology Venereol"},{"key":"4031_CR39","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/S0140-6736(12)61140-4","volume":"381","author":"E Schmidt","year":"2013","unstructured":"Schmidt E, Zillikens D (2013) Pemphigoid diseases. Lancet 381:320\u2013332","journal-title":"Lancet"},{"key":"4031_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-021-03192-8","volume":"19","author":"K Chouchane","year":"2021","unstructured":"Chouchane K, Di Zenzo G, Pitocco D, Calabrese L, De Simone C (2021) Bullous pemphigoid in diabetic patients treated by gliptins: the other side of the coin. J Translational Med 19:1\u201310","journal-title":"J Translational Med"},{"issue":"8","key":"4031_CR41","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1007\/s00403-023-02562-0","volume":"315","author":"W Guo","year":"2023","unstructured":"Guo W, Rathi S, Marquez J, Smith H, Kuruvilla A, Tonnesen MG, Salvemini JN (2023) Prevalence of diabetes mellitus in bullous pemphigoid patients in the absence of dipeptidyl peptidase-4 inhibitors: a systematic review and meta-analysis. Arch Dermatol Res 315(8):2207\u20132213","journal-title":"Arch Dermatol Res"},{"key":"4031_CR42","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1001\/jamadermatol.2018.2352","volume":"154","author":"K Kridin","year":"2018","unstructured":"Kridin K, Bergman R (2018) Association of bullous pemphigoid with Dipeptidyl-Peptidase 4 inhibitors in patients with diabetes: estimating the risk of the new agents and characterizing the patients. JAMA DermatoL 154:1152\u20131158","journal-title":"JAMA DermatoL"},{"key":"4031_CR43","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1016\/j.jid.2018.01.027","volume":"138","author":"O Varpuluoma","year":"2018","unstructured":"Varpuluoma O, F\u00f6rsti AK, Jokelainen J, Turpeinen M, Timonen M, Huilaja L, Tasanen K (2018) Vildagliptin significantly increases the risk of bullous pemphigoid: A Finnish nationwide registry study. J Invest Dermatol 138:1659\u20131661","journal-title":"J Invest Dermatol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-025-04031-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-025-04031-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-025-04031-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T08:02:34Z","timestamp":1742198554000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-025-04031-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,17]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4031"],"URL":"https:\/\/doi.org\/10.1007\/s00403-025-04031-2","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,17]]},"assertion":[{"value":"17 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for reporting individual cases or case series is not required. The authors state that this research was conducted following the Helsinki Declaration as revised in 2008.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from the patient for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"569"}}